• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Diseases & Conditions
  • All Diseases and Conditions
  • Study of Incidence of Drug-induced Upper Gastrointestinal Bleeding

Disease
gastrointestinal bleeding
Drug Name
Nexium
Generic Name
OMEPRAZOLE
Sponsor
AstraZeneca
Drug Status
Approved Medicine
Phase
Non-Interventional Study
Start Date
Jun 22, 2010
Study Name
NIS-GRU-NEX-2009/2
Study Id
NIS-GRU-NEX-2009/2
ClinicalTrials.gov ID
NCT01155401
Recruiting Status
Open
Protocol Status
Not Available
Report
Feb 24, 2012
  • NIS-GRU-NEX-2009_2.pdf (405 KB)

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013